Zhejiang Medicine(600216) holds a 49.06% stake in Xiamen Huaben Qihang Equity Investment Partnership (Limited Partnership).

2026-03-06 07:15:49

Abstract generation in progress

Securities Star News reports that according to Tianyancha app data, recently, Xiamen Huaben Qihang Equity Investment Partnership (Limited Partnership) was established. The legal representative is Xiamen Huaben Contemporary Venture Capital Management Co., Ltd., with a registered capital of 320 million yuan. The business scope includes: general items—engaging in equity investment, investment management, asset management, and other activities through private equity funds (business activities can only be conducted after registration and filing with the Asset Management Association of China); venture capital investment (limited to investments in unlisted companies). (Except for projects that require approval by law, the company conducts business activities independently with a business license). Tianyancha app’s equity penetration shows that the company is jointly held by Zhejiang Medicine, Cai Xiaoyang, Yu Fengjia, and others.

Data source: Tianyancha app

The above content is compiled by Securities Star based on publicly available information, generated by AI algorithms (Wang Xin Suan Bei 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.